Abstract
AbstractExtracts of Ginkgo biloba L. are one of the most commonly applied herbal medicines. The active constituents are flavonol glycosides and terpene trilactones in particular. The special extract EGb 761® is mentioned in the German S3 clinical guideline “Demenzen” as treatment option (“kann” recommendation). Some small- and large-scale clinical studies for Ginkgo biloba leaf extracts are summarized in this publication for the indications: Tardive dyskinesia, vitiligo, anxiety/anxiety disorder, visual impairment, mountain sickness, sudden hearing loss, attention deficient hyperactivity disorder (ADHD) in children and fatigue. The studies are of different quality and show variable results. More research is warranted to draw conclusions about the effectiveness of Ginkgo biloba extracts for those indications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
